ESSA Pharma Cash Flow - Quarterly (NASDAQ:EPIX)

Add to My Stocks
$3.07 $0.2 (6.12%) EPIX stock closing price Sep 18, 2018 (Closing)

The financial analysis of EPIX requires an investor to check the cash flows for ESSA Pharma. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For ESSA Pharma profits one has to check the income statement and for ESSA Pharma debt one has to check the balance sheet. ESSA Pharma had cash and cash equivalents of $3.96M at beginning of the quarter and $18.06M at quarter end of 2018 Q3. ESSA Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. ESSA Pharma had an outflow of $-7.98M from operating activities, $22.11M inflow due to financing activities, and $- outflow due to investing activities till 2018 Q3.

View and download details of ESSA Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.25M--0.04M-1.69M-1.17M-0.31M-1.88M2.32M--0.26M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.59M---10.98M-10.64M-2.82M-6.14M-4.55M-3.95M-3.24M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment--------0.01M-0.01M-0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities24.72M--8M8M8M8M---
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-2.61M22.91M-0.14M4.32M4.68M4.88M-0.16M22.7M22.7M22.93M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.02M-------0.02M-0.02M-0.08M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year3.96M8.98M1.57M3.17M------
Cash & Equivalents at Year End18.06M21.69M1.86M3.95M7.32M12.61M10.85M8.98M12.37M15.93M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

ESSA Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of ESSA Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that ESSA Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - ESSA Pharma stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. ESSA Pharma lost $-7.98M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for EPIX stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $22.11M for ESSA Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For ESSA Pharma Cash Flow